Publication | Closed Access

Evaluation of regulatory T cells (Tregs) alterations in patients with multiple myeloma treated with bortezomib or lenalidomide plus dexamethasone: correlations with treatment outcome

Hematological MalignancyTreatment OutcomeMedicineImmunologyHematologyRegulatory T CellsAutoimmunityMultiple MyelomaAdult T-cell Leukemia-lymphomaImmunotherapyOncologyRadiation OncologyHealth Sciences